21 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 28554725 | Substrate inhibition of 17β-HSD1 in living cells and regulation of 17β-HSD7 by 17β-HSD1 knockdown. | 2017 Sep | 1 |
2 | 28977936 | The regulation of hydroxysteroid 17β-dehydrogenase type 1 and 2 gene expression in breast cancer cell lines by estradiol, dihydrotestosterone, microRNAs, and genes related to breast cancer. | 2017 Sep 22 | 1 |
3 | 25257817 | Reductive 17beta-hydroxysteroid dehydrogenases which synthesize estradiol and inactivate dihydrotestosterone constitute major and concerted players in ER+ breast cancer cells. | 2015 Jun | 1 |
4 | 24434280 | Human 3-alpha hydroxysteroid dehydrogenase type 3 (3α-HSD3): the V54L mutation restricting the steroid alternative binding and enhancing the 20α-HSD activity. | 2014 May | 1 |
5 | 24787657 | Understanding androgen action in adipose tissue. | 2014 Sep | 1 |
6 | 23647539 | A challenge for medicinal chemistry by the 17β-hydroxysteroid dehydrogenase superfamily: an integrated biological function and inhibition study. | 2013 | 2 |
7 | 20172961 | 17beta-hydroxysteroid dehydrogenase type 1 stimulates breast cancer by dihydrotestosterone inactivation in addition to estradiol production. | 2010 Apr | 9 |
8 | 19038308 | Reductive 17beta-hydroxysteroid dehydrogenases in the sulfatase pathway: critical in the cell proliferation of breast cancer. | 2009 Mar 25 | 4 |
9 | 15862963 | Cloning and characterization of human form 2 type 7 17beta-hydroxysteroid dehydrogenase, a primarily 3beta-keto reductase and estrogen activating and androgen inactivating enzyme. | 2005 Feb | 2 |
10 | 15882060 | Mapping of steroids binding to 17 beta-hydroxysteroid dehydrogenase type 1 using Monte Carlo energy minimization reveals alternative binding modes. | 2005 May 17 | 1 |
11 | 15666817 | Cellular specific expression of the androgen-conjugating enzymes UGT2B15 and UGT2B17 in the human prostate epithelium. | 2004 Nov | 2 |
12 | 12490543 | Pseudo-symmetry of C19 steroids, alternative binding orientations, and multispecificity in human estrogenic 17beta-hydroxysteroid dehydrogenase. | 2003 Feb | 6 |
13 | 11165020 | Inhibitors of type II 17beta-hydroxysteroid dehydrogenase. | 2001 Jan 22 | 2 |
14 | 11336660 | Human oestrogenic 17beta-hydroxysteroid dehydrogenase specificity: enzyme regulation through an NADPH-dependent substrate inhibition towards the highly specific oestrone reduction. | 2001 May 15 | 2 |
15 | 11711113 | Modulatory effects of indomethacin on androgen metabolism in human gingival and oral periosteal fibroblasts. | 2001 Dec | 1 |
16 | 10625652 | Dehydroepiandrosterone and dihydrotestosterone recognition by human estrogenic 17beta-hydroxysteroid dehydrogenase. C-18/c-19 steroid discrimination and enzyme-induced strain. | 2000 Jan 14 | 3 |
17 | 10419021 | 3D-structure of human estrogenic 17beta-HSD1: binding with various steroids. | 1999 Apr-Jun | 1 |
18 | 10428369 | Spironolactone-related inhibitors of type II 17beta-hydroxysteroid dehydrogenase: chemical synthesis, receptor binding affinities, and proliferative/antiproliferative activities. | 1999 Jun | 1 |
19 | 7546291 | The human type II 17 beta-hydroxysteroid dehydrogenase gene encodes two alternatively spliced mRNA species. | 1995 Oct | 1 |
20 | 7759109 | Mapping of the HSD17B2 gene encoding type II 17 beta-hydroxysteroid dehydrogenase close to D16S422 on chromosome 16q24.1-q24.2. | 1995 Feb 10 | 1 |
21 | 8380373 | Androgen receptor-mediated stimulation of 17 beta-hydroxysteroid dehydrogenase activity by dihydrotestosterone and medroxyprogesterone acetate in ZR-75-1 human breast cancer cells. | 1993 Jan | 1 |